417 related articles for article (PubMed ID: 18473435)
1. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
2. Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analogues.
Nakagawa-Goto K; Chang PC; Lai CY; Hung HY; Chen TH; Wu PC; Zhu H; Sedykh A; Bastow KF; Lee KH
J Med Chem; 2010 Sep; 53(18):6699-705. PubMed ID: 20735140
[TBL] [Abstract][Full Text] [Related]
3. Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.
Su CR; Yeh SF; Liu CM; Damu AG; Kuo TH; Chiang PC; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2009 Aug; 17(16):6137-43. PubMed ID: 19635670
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
5. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
6. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
7. Novel multidrug resistance reversal agents.
Berger D; Citarella R; Dutia M; Greenberger L; Hallett W; Paul R; Powell D
J Med Chem; 1999 Jun; 42(12):2145-61. PubMed ID: 10377220
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines.
De Vincenzo R; Scambia G; Ferlini C; Distefano M; Filippini P; Riva A; Bombardelli E; Pocar D; Gelmi ML; Benedetti Panici P; Mancuso S
Anticancer Drug Des; 1998 Jan; 13(1):19-33. PubMed ID: 9474240
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
[TBL] [Abstract][Full Text] [Related]
11. A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways.
Kuo TC; Chiang PC; Yu CC; Nakagawa-Goto K; Bastow KF; Lee KH; Guh JH
Biochem Pharmacol; 2011 May; 81(9):1136-44. PubMed ID: 21371443
[TBL] [Abstract][Full Text] [Related]
12. Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells.
Zhang PY; Wong IL; Yan CS; Zhang XY; Jiang T; Chow LM; Wan SB
J Med Chem; 2010 Jul; 53(14):5108-20. PubMed ID: 20560605
[TBL] [Abstract][Full Text] [Related]
13. Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring.
Lee Y; Yeo H; Liu SH; Jiang Z; Savizky RM; Austin DJ; Cheng YC
J Med Chem; 2004 Oct; 47(22):5555-66. PubMed ID: 15481991
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
[TBL] [Abstract][Full Text] [Related]
15. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships.
Sarek J; Klinot J; Dzubák P; Klinotová E; Nosková V; Krecek V; Korínková G; Thomson JO; Janost'áková A; Wang S; Parsons S; Fischer PM; Zhelev NZ; Hajdúch M
J Med Chem; 2003 Dec; 46(25):5402-15. PubMed ID: 14640549
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs.
Nakagawa-Goto K; Bastow KF; Wu JH; Tokuda H; Lee KH
Bioorg Med Chem Lett; 2005 Jun; 15(12):3016-9. PubMed ID: 15913998
[TBL] [Abstract][Full Text] [Related]
17. Benzoylphenylurea sulfur analogues with potent antitumor activity.
Hallur G; Jimeno A; Dalrymple S; Zhu T; Jung MK; Hidalgo M; Isaacs JT; Sukumar S; Hamel E; Khan SR
J Med Chem; 2006 Apr; 49(7):2357-60. PubMed ID: 16570932
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of some taxoids as multidrug resistance modulator.
Hasegawa T; Bai J; Zhang S; Wang J; Matsubara J; Kawakami J; Tomida A; Tsuruo T; Hirose K; Sakai J; Kikuchi M; Abe M; Ando M
Bioorg Med Chem Lett; 2007 Feb; 17(4):1122-6. PubMed ID: 17239597
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
20. Papyriferic acid derivatives as reversal agents of multidrug resistance in cancer cells.
Xiong J; Taniguchi M; Kashiwada Y; Sekiya M; Yamagishi T; Takaishi Y
Bioorg Med Chem; 2010 Apr; 18(8):2964-75. PubMed ID: 20363142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
